Novo CEO pressed by Senate to chop price ranges of obesity, diabetes medications CEO Lars Fruergaard Jørgensen instructed lawmakers the company would take into account new talks with insurers with regards to the record prices of Wegovy and copyright whenever they pledge to keep the medicines on their own formularies. https://gunnerwndsj.blogs100.com/31110480/a-simple-key-for-healthcare-news-unveiled